Radnost™ prognostic will enable clinicians to develop a customised radiation cancer treatment plan that delivers vastly improved patient outcomes. An innovative algorithm derived from laser-based technology, leverages the universality of radiation action to provide unprecedented insights that can be utilised in conjunction with any current form of radiation treatment, as well as integrated with wider clinical information.

The science
behind our name

Radiotherapy

Prognostic

radnos

The Challenge

Radiotherapy for the treatment of cancer is by and large offerred as a one-size-fits-all approach. To date, there is no regulatory-approved radiation prognostic test in the market, meaning an individual’s  response is impossible to predict with any certainty. Clinicians provide patients with outcome data based on median or mean response times and strive to provide more precise personalised information and reassurance, addressing their questions at an incredibly vulnerable time.

With a prognosis following radiotherapy being well understood, it is widely recognised that there is a bell curve of response to radiotherapy, with some patients doing exceptionally well, and others not so. With Radnost™, we are on a mission to replace that uncertainty using clinically backed scientific results, giving an individual a clear picture of their cancers responsiveness to radiotherapy. Clinicians demand it, patients deserve it and Radnost™ delivers it.

 Learn more

Revolutionising
cancer treatment

This incredible new radiation prognostic tool is projected to enhance cure rates for most cancer types. It will revolutionise how we think about cancer treatment for the future.

Why Radnost™ ?

A scientifically proven tool specifically designed to empower clinicians with vital data and information. It will determine the most efficacious treatment pathway for each individual patient.

Targeted and precise:
Scientific data will determine whether radiotherapy is appropriate, indicate an effective treatment pathway and ultimately improve outcomes
Pan cancer purpose:
Analyses ALL solid cancer tumours
Rapid results:
Tumour scores can be determined within 3-5 days, enabling clinicians to reassure patients with faster treatment options
Affordable:
Relatively inexpensive and accessible to all patients
Reduced side effects:
Radnost™ enables the clinician to reduce the likelihood of any unnecessary treatment steps helping to alleviate both emotional and physical patient side effects

Contact us

If you want to learn more or talk to us please feel free to get in touch at connect@atomiconcology.com.au